Anti-inflammatory activity of N-ethoxycarbonyl-3-benzoyltrifluoromethanesulfonanilide (MBR 4223, triflumidate), a new nonsteroidal compound.
D000704:Analysis of Variance; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy; D001565:Benzoates / Q000627:therapeutic use; D001577:Benzophenones; D001681:Biological Assay; D002351:Carrageenan; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy*; D004890:Erythema / Q000188:drug therapy; D005461:Fluorine / Q000627:therapeutic use; D006168:Guinea Pigs; D006614:Hindlimb; D008297:Male; D010653:Phenylbutazone / Q000627:therapeutic use; D051381:Rats; D013449:Sulfonamides / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D001565:Benzoates; D001577:Benzophenones; D013449:Sulfonamides; D005461:Fluorine; D002351:Carrageenan; D010653:Phenylbutazone; C003651:triflumidate